[go: up one dir, main page]

RU2018125503A - NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN - Google Patents

NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN Download PDF

Info

Publication number
RU2018125503A
RU2018125503A RU2018125503A RU2018125503A RU2018125503A RU 2018125503 A RU2018125503 A RU 2018125503A RU 2018125503 A RU2018125503 A RU 2018125503A RU 2018125503 A RU2018125503 A RU 2018125503A RU 2018125503 A RU2018125503 A RU 2018125503A
Authority
RU
Russia
Prior art keywords
amount
composition according
paragraphs
brain
myelination
Prior art date
Application number
RU2018125503A
Other languages
Russian (ru)
Inventor
Нора ШНАЙДЕР
Шон ДЕОНИ
Тамаш БАРТФАИ
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Priority claimed from PCT/EP2016/080781 external-priority patent/WO2017108500A1/en
Publication of RU2018125503A publication Critical patent/RU2018125503A/en

Links

Landscapes

  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (24)

1. Питательная композиция для младенца и/или детей младшего возраста, содержащая витамин или смеси витаминов, для стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге. 1. A nutritional composition for an infant and / or young children, containing vitamin or mixtures of vitamins, to stimulate and / or maintain the optimal path of myelination in the brain. 2. Композиция по п. 1, причем оптимальная траектория миелинизации в головном мозге близка к траектории, наблюдаемой у младенцев, получавших исключительно человеческое грудное молоко в течение первых месяцев жизни.2. The composition according to claim 1, wherein the optimal path of myelination in the brain is close to the path observed in infants who received exclusively human breast milk during the first months of life. 3. Композиция по любому из пп. 1 или 2, причем она стимулирует и/или поддерживает состояние здоровья, характеризующееся оптимальным развитием головного мозга и когнитивных функций и/или профилактикой нейрокогнитивных расстройств. 3. The composition according to any one of paragraphs. 1 or 2, and it stimulates and / or maintains a state of health characterized by optimal development of the brain and cognitive functions and / or prevention of neurocognitive disorders. 4. Композиция по любому из пп. 1-3, которая содержит фолиевую кислоту в количестве более 50 мкг/100 г и/или витамин В12 в количестве более 0,01 мкг/100 г.4. The composition according to any one of paragraphs. 1-3, which contains folic acid in an amount of more than 50 μg / 100 g and / or vitamin B12 in an amount of more than 0.01 μg / 100 g 5. Композиция по любому из пп. 1-4, которая также содержит железо.5. The composition according to any one of paragraphs. 1-4, which also contains iron. 6. Композиция по любому из пп. 1-5, которая также содержит DHA.6. The composition according to any one of paragraphs. 1-5, which also contains DHA. 7. Композиция по любому из пп. 1-6, которая также содержит сфингомиелин.7. The composition according to any one of paragraphs. 1-6, which also contains sphingomyelin. 8. Композиция по любому из пп. 1-7, которая также содержит холин.8. The composition according to any one of paragraphs. 1-7, which also contains choline. 9. Применение композиции по любому из пп. 1-8 для стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге у младенца или детей младшего возраста.9. The use of the composition according to any one of paragraphs. 1-8 to stimulate and / or maintain an optimal trajectory of myelination in the brain in an infant or young children. 10. Применение композиции по любому из пп. 1-8 для профилактики субоптимальной траектории миелинизации в головном мозге у младенца или детей младшего возраста.10. The use of the composition according to any one of paragraphs. 1-8 for the prevention of a suboptimal trajectory of myelination in the brain in an infant or young children. 11. Способ стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге у младенца и/или детей младшего возраста, включающий введение такому младенцу и/или детям младшего возраста питательной композиции, содержащей фолиевую кислоту.11. A method of stimulating and / or maintaining an optimal path of myelination in the brain in an infant and / or young children, comprising administering to such an infant and / or young children a nutritional composition containing folic acid. 12. Способ по п. 11, в котором композицию по любому из пп. 1-8 вводят младенцу и/или детям младшего возраста.12. The method according to p. 11, in which the composition according to any one of paragraphs. 1-8 is administered to an infant and / or young children. 13. Питательная композиция, содержащая:13. A nutritional composition comprising: сфингомиелин в количестве более 200 мг/кг;sphingomyelin in an amount of more than 200 mg / kg; железо в количестве более 5 мг/100 г;iron in an amount of more than 5 mg / 100 g; холин в количестве более 30 мг/100 г;choline in an amount of more than 30 mg / 100 g; DHA в количестве более 30 мг/100 г;DHA in an amount of more than 30 mg / 100 g; фолиевую кислоту в количестве более 50 мкг/100 г; и или витамин B12 в количестве более 0,01 мкг/100 г.folic acid in an amount of more than 50 μg / 100 g; and or vitamin B12 in an amount of more than 0.01 mcg / 100 g. 14. Питательная композиция, содержащая:14. A nutritional composition comprising: сфингомиелин в количестве в диапазоне от 200 мг до 2 г/кг;sphingomyelin in an amount in the range from 200 mg to 2 g / kg; железо в количестве в диапазоне от 5 до 40 мг/100 г;iron in an amount in the range from 5 to 40 mg / 100 g; холин в количестве в диапазоне от 30 до 1000 мг/100 г;choline in an amount in the range from 30 to 1000 mg / 100 g; DHA в количестве в диапазоне от 30 до 300 мг/100 г;DHA in an amount ranging from 30 to 300 mg / 100 g; фолиевую кислоту в количестве в диапазоне от 50 до 500 мкг/100 г; витамин B12 в количестве более 0,1-10 мкг/100 г.folic acid in an amount in the range from 50 to 500 μg / 100 g; vitamin B12 in an amount of more than 0.1-10 mcg / 100 g.
RU2018125503A 2015-12-14 2016-12-13 NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN RU2018125503A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP15199758.2 2015-12-14
EP15199758 2015-12-14
US201662315312P 2016-03-30 2016-03-30
US201662315249P 2016-03-30 2016-03-30
US62/315,249 2016-03-30
US62/315,312 2016-03-30
US201662328070P 2016-04-27 2016-04-27
US62/328,070 2016-04-27
PCT/EP2016/080781 WO2017108500A1 (en) 2015-12-14 2016-12-13 Nutritional compositions and infant formulas to promote myelination in the brain

Publications (1)

Publication Number Publication Date
RU2018125503A true RU2018125503A (en) 2020-01-16

Family

ID=65529023

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018125503A RU2018125503A (en) 2015-12-14 2016-12-13 NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN

Country Status (3)

Country Link
CL (1) CL2018001595A1 (en)
MX (1) MX2018006296A (en)
RU (1) RU2018125503A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
EP4233904A3 (en) 2015-12-14 2024-01-10 Société des Produits Nestlé S.A. Compositions and their use

Also Published As

Publication number Publication date
CL2018001595A1 (en) 2018-10-19
MX2018006296A (en) 2019-08-21

Similar Documents

Publication Publication Date Title
PH12019550208B1 (en) Hmos blends for use in infants or young children for health purposes
PH12020550341A1 (en) Niraparib formulations
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
KR20020025088A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
RU2011150191A (en) LACTOFERRIN AND NEURAL HEALTH AND INTESTINAL DEVELOPMENT IN INFANTS
PH12017500467A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or children
BR112015022995A2 (en) infant nutritional product with rrr-alpha tocopherol
JP2015533509A5 (en)
PH12018500866A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
RU2011150189A (en) PREVENTION AND TREATMENT OF ALLERGIC DIARRHEA
PH12012502526A1 (en) Early programming of brain function through soy protein feeding
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
RU2018125503A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN
RU2018125702A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN
RU2014132846A (en) GLUTAMINE-ENRICHED NUTRITION FOR INFANTS
PH12016500772A1 (en) Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function
RU2018125497A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES FOR ACTIVATING MYELINATION IN THE BRAIN
RU2018127013A (en) MEDICINE CONTAINING ARIPIPRAZOL AND CYLOSTASOL
PH12018501150A1 (en) Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
RU2016112528A (en) LACTOFERRIN, IMPROVEMENT OF MEMORY AND IMPROVEMENT OF SPEED OF LEARNING IN CHILDREN
RU2014132852A (en) GLUTAMINE-ENRICHED NUTRITION FOR INFORMATION IN PREGNANT BREAST CHILDREN
EA202193041A1 (en) MULTILAYER PHARMACEUTICAL OR NUTRICEUTIC SOLID DOSAGE FORMS CONTAINING PYRIMIDINE AND/OR PURINE DERIVATIVES AND VITAMINS B, THEIR PREPARATION AND APPLICATION
JP2018500284A5 (en)
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
MX2016003327A (en) Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use.

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20191216